Wang et al. found that the expression level of ACSL1 is significantly associated with the levels of various acyl-CoAs including C16:0-, C18:0-, C18:1-, and C18:2-CoA, triglycerides, and lipids in cancer cells and is elevated in prostate tumors [23]. The gene discussed is ACSL1; the disease is cancer.